The therapy of ductal carcinoma in situ (DCIS) is controversial but is being increasingly decided by pathologic evidence. Studies of the natural history of DCIS demonstrate that DCIS is very heterogeneous in its clinical behavior. As detailed in several reviews, studies that followed patients after biopsy alone indicate a great difference between the small noncomedo examples of DCIS and the larger comedo DCIS lesions. The currently available evidence from cases that have been treated by planned surgical excision without radiation therapy would indicate that noncomedo examples of DCIS have a low incidence of recurrence and may be adequately treated by this technique. In contrast, comedo DCIS lesions have a high propensity for recurrence despite excision and radiotherapy. This presentation will review the histopathology of DCIS and highlight the idea that we are currently in a state of transition in our understanding of DCIS. Studies supporting the stratification of DCIS by histologic pattern plus cytology and size will be contrasted with the rapidly disappearing classic posture that all DCIS is biologically similar and treatment options need not be stratified by the different subtypes or varieties of DCIS. Key Words: Ductal carcinoma in situ-Breast. Pathol 27(6): 828-831, 2003. 
SIZE OR EXTENT OF DUCTAL CARCINOMA IN SITU
The range of clinical presentations of ductal carcinoma in situ (DCIS) is immense, extending from large, palpable masses to the tiniest examples that overlap occasionally with atypical ductal hyperplasia 16, 19 using current criteria. These smaller lesions should be recognized as being almost trivial. Size criteria have been helpful at this low end of the DCIS spectrum because lesions that are in the range of 2-5 mm in size are regularly circumscribed and usually adequately removed by the initial biopsy procedures. The natural history of these smaller lesions, without attempts at margin assessment, is detailed in articles published in 1978 2 and 1982. 1, 5 The larger examples of DCIS, usually with comedo features, are also well known. They have been assumed to be multicentric in the past, but recent studies with careful three-dimensional reconstruction 11 make it clear that these lesions are continuous in three dimensions in almost all cases. The biologic event underlying this spread or involvement of much of the breast by a histologically similar process is not yet known. The more extensive examples with higher-grade nuclei are often also associated with Paget's disease of the nipple.
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HISTOLOGIC TYPE
There is a wide recent acceptance of the heterogeneity of DCIS. 7, 13, 27 Furthermore, many accept that cytology and histologic pattern (Table 1) can be used together to make assignment into categories more precise, reproducible, and clinically useful.
The close association of nuclear abnormalities and the presence of necrosis identified microscopically have resulted in several classification proposals that are quite parallel despite slightly different terminology. Both the recently proposed Van-Nuys histologic classification 23 and an approach proposed and tested for interobserver variation by Scott et al. 22 use slight modifications in the Lagios classification first proposed in 1989, 12 although collapsed from four tiers to three. Basically, the systems recognize high-grade categories with necrosis and a high degree of nuclear atypia and a low-grade group with orderly nuclei and no necrosis. An intermediate group helps refine the assignment of cases in the high and low groups by accepting cases with intermediate grade nuclei and limited necrosis.
Some pathologists have used histologic pattern and cytologic grade as separate determinants, but this approach negates the precise identification of the highest and lowest grade lesions. It is the determination of the highest and lowest grade lesions by the combined approach that is most likely to determine whether the lesion may be cured by conservative treatment as indicated by the work of Lagios et al. 12 Initially, they separated lesions into four categories with the top two categories having advanced nuclear atypia and necrosis, separated only by the remnants of a micropapillary or cribriform pattern in one of the categories. Upon further scrutiny, Lagios et al. 12 combined these two categories. Thus, there is no utility in recognizing minor remnants of cribriform or micropapillary pattern in high-grade lesions because a large percentage of these cases recurred after planned wide excision. It is precisely this approach of using pathoanatomic principles to identify clinically useful endpoints that distinguishes the modern approach to histopathology from the historical descriptive approach. It is evident that the lower grade, noncomedo lesions are likely to be smaller and also may be amenable to treatment with very low recurrence rates (Table 2) .
There is a suggestion, as yet only documented in two studies, 1, 17 that the pure micropapillary pattern of DCIS (not combined with other patterns) may be associated more frequently with quite extensive disease. This is not true if occasional micropapilli are intermixed with the solid and cribriform patterns, a relatively common finding.
DIFFERENTIAL DIAGNOSIS
There has been a lack of concordance between different pathologists in determining whether small lesions should be considered atypical hyperplasia or in situ carcinoma. In general, lesions that involve only a few membrane-bound spaces and measure <2-3 mm in greatest dimension should be regarded as hyperplastic lesions (with or without atypia) and not in situ carcinoma. There is a greater degree of concordance in larger lesions. 19 Even the diagnosis of difficult, smaller, borderline lesions will approach concordance between observers if pathologists agree on criteria 2 (Table 3) .
CLINICAL OUTCOME
Several studies have assessed the risk of subsequent invasive carcinoma for patients in whom the diagnosis of DCIS was not made at the initial biopsy for small, noncomedo lesions. Approximately one third of these patients developed invasive breast cancer in the same region of the same breast within 10-18 years. Thus, it would appear that small examples of noncomedo DCIS are nonobligate precursor lesions. If one accepts the fact that some of the lesions in the 1978 2 and 1982 15 articles were completely removed, it is likely that the progression rate of noncomedo DCIS to invasive cancer over a prolonged period of time approaches 50%. For comedo DCIS, attempted wide excision of large lesions is notoriously unsuccessful, 8, 25 and recurrences in this setting are much more commonly associated with progression to invasion and with distant metastases. 5 Developing evidence strongly supports the idea that adequate excision of DCIS lesions without radiotherapy (Table 2 ) may lead to cure. 9 As noted in other sections of this review, smaller noncomedo examples of DCIS are regularly treated successfully at least with follow-up extending to 7 or 8 years. 1, 14, 20, 21 These surgical protocols have used planned, wide excisions, with carefully documented margins. Most of the cases have been mammographically detected, but a few cases discovered incidentally have been successfully treated also. 6, 24 The recent EORTC trial for DCIS has shown that local excision can also be used for Paget's disease of the nipple. 4 
ROLE OF RADIATION
What is the role of radiotherapy in reducing local recurrence after wide excision of a localized area of DCIS? Preliminary data (with follow-up of <4 years) from a study in the United States 10 suggests that radiotherapy may reduce the rate of disease recurrence within the breast following an adequate excision of a localized area of DCIS. It is not clear from this study whether the benefits of radiotherapy relate to all types of DCIS or whether the benefits will be demonstrable beyond 43 months of follow-up. To determine the optimum treatment for DCIS detected in screening programs, a number of clinical trials are underway. It is widely accepted that the mammographically detected DCIS lesion should be considered separately from the regularly larger lesions presenting with palpable masses and nipple discharge. 18 Whether radiation therapy aids in retarding or negating recurrence in some lesions awaits careful subtype analysis of such cases. However, the relevance of stratification by histologic pattern is well demonstrated in groups of patients treated by radiotherapy after surgical excision. 26 It would appear that small examples of noncomedo DCIS are nonobligate precursor lesions, and only 25-30% of them eventuate in invasive carcinomas if left untreated. They may be regarded as increased risk lesions because their relative risk of later invasive cancer development is about 10 times that of the general population. It is obvious that if adequately removed surgically, small examples of noncomedo DCIS may be regarded as cured. It is by no means guaranteed, however, that carcinoma will not develop elsewhere within these breasts in follow-up, just that it should be the exception rather than the rule.
Complete embedding of the lesion with accounting for the three-dimensional extent of the disease within the breast is critical for conservative treatment of DCIS. Almost any case of DCIS excised with a 1-cm margin should not recur locally. 26 What has not been established is that all cases of DCIS that are amenable to local excision for cure require a 1-cm margin. An Eastern Oncology Cooperative Group Trial (ECOG 5194) is currently accruing patients to determine which DCIS lesions may be cured by local excision alone. Entry criteria include complete submission of the lesion by sequential sectioning, margins clear of DCIS by at least 3 mm, and size of the DCIS Յ1 cm for high-grade and Յ2.5 cm for intermediate-or low-grade DCIS. Patients are accepted into this trial after central review of their slides.
In summary, there is strong evidence that small size and low histologic grade interact to produce lesions easily cured by local excision without radiation therapy. This is certainly true of lesions that are <1 cm in largest diameter. Thus, the best estimate of size of a DCIS lesion should be stated even for core biopsy specimens to facilitate clinical management. The greatest extent of a lesion is assessed most easily by careful pathologicmammographic correlation, which is mandatory in most instances. It is also clear that extensive high-grade, comedo lesions are not easily cured and that recurrences are common even after radiation therapy. 25 Precisely which concurrence of histologic grade, size, and margin clearance is to be the determinant of therapeutic decisionmaking is an area under investigation currently. However, it should be understood that local recurrence in the setting of a low-grade lesion is very unlikely to be a life-threatening event and that a woman's desire for breast conservation with a willingness to accept the possibility of local recurrence may be as important with regard to therapeutic decision-making as any other consideration. In contrast, local recurrence in the setting of a high-grade DCIS lesion is much more likely to be associated with invasion, high-grade histology, and distant metastases. 3, 5 Thus, careful pathologic assessment of DCIS lesions that includes histologic pattern, grade, size, and margin status is essential for optimal clinical management, and we owe our clinical colleagues and, more importantly, our patients nothing less. 
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